Tandem Diabetes Care Inc (STU:TD5A)
€ 29.15 -1.65 (-5.36%) Market Cap: 1.92 Bil Enterprise Value: 1.92 Bil PE Ratio: 0 PB Ratio: 8.66 GF Score: 82/100

Tandem Diabetes Care Inc at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 05:55PM GMT
Release Date Price: €45.54 (+3.18%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

All right. Welcome, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with Tandem Diabetes. With us, we have John Sheridan, President and CEO; and Leigh Vosseller, Executive Vice President and CFO.

In terms of format, it's going to be a fireside chat. If anybody has a question they want to ask, just raise your hand, and we'll call on you.

John and Leigh, thanks so much for being here.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks for having us, Larry. Good to see you again.

Questions & Answers

Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst

Likewise. So John, we're starting all these fireside chats with the macro environment. And on the Q2 call, you highlighted 3 headwinds that resulted in lower-than

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot